NASDAQ · FYC
First Trust Small Cap Growth AlphaDEX Fund
$114.03-$2.77 (-2.37%)
First Trust Small Cap Growth AlphaDEX Fund’s quoted price sits in the upper half of its reported 52-week range, 10.61% below the high.
Loading market information…
NASDAQ · PPH · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
VanEck Pharmaceutical ETF’s forward annual dividend is $1.44 per share, paid quarterly. The forward yield is 1.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 11:14 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$114.03-$2.77 (-2.37%)
First Trust Small Cap Growth AlphaDEX Fund’s quoted price sits in the upper half of its reported 52-week range, 10.61% below the high.
$107.61+$1.00 (+0.94%)
iShares U.S. Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.66% below the high.
$66.71-$0.57 (-0.84%)
Longview Advantage ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$39.23-$0.50 (-1.26%)
BNY Mellon US Mid Cap Core Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 6.75% below the high.
$64.86-$3.55 (-5.19%)
Sprott Gold Miners ETF’s quoted price sits in the lower half of its reported 52-week range, 32.79% below the high.
$257.98+$1.08 (+0.42%)
VanEck Biotech ETF’s quoted price sits in the upper half of its reported 52-week range, 1.76% below the high.
$29.81-$0.03 (-0.1%)
Harbor International Compounders ETF (OSEA)’s quoted price sits in the upper half of its reported 52-week range, 5.66% below the high.
$16.65-$0.29 (-1.71%)
VanEck Vietnam ETF’s quoted price sits in the lower half of its reported 52-week range, 16.15% below the high.
